Bisphenol A (BPA) acts as an endocrine disruptor in women with Polycystic Ovary Syndrome: Hormonal and metabolic evaluation

Obesity Medicine - Tập 14 - Trang 100090 - 2019
Iram Ashaq Kawa1, Akbar Masood1, Mohd Ashraf Ganie2, Qudsia Fatima1, Humira Jeelani1, Saika Manzoor1, Syeed Masuma Rizvi3, Mohd. Muzamil4, Fouzia Rashid1
1Department of Biochemistry/Clinical Biochemistry, University of Kashmir, Srinagar, India
2Sheri Kashmir Institute of Medical Sciences, Srinagar, India
3Department of Obstetrics and Gynecology, Government Medical College, Srinagar, India
4Department of Psychology, University of Kashmir, Srinagar, India

Tài liệu tham khảo

Aleem, 2013, Haematological related perturbations in polycystic ovarian syndrome: a tertiary centre experience, Glob. Res. Anal., 2, 2277 Alonso-Magdalena, 2006, The estrogenic effect of bisphenol A disrupts pancreatic Î2-cell function in vivo and induces insulin resistance, Environ. Health Perspect., 114, 106, 10.1289/ehp.8451 Ãzr, 2014, Association between red blood cell distribution width and polycystic ovary syndrome, Endocr. Res., 40, 181 Azziz, 2006, Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature, J. Clin. Endocrinol. Metab., 91, 781, 10.1210/jc.2005-2153 Batista, 2012, Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice, PLoS One, 7, 10.1371/journal.pone.0033814 Brieno-Enriquez, 2011, Human meiotic progression and recombination are affected by Bisphenol A exposure during in vitro human oocyte development, Hum. Reprod., 26, 2807, 10.1093/humrep/der249 Cabaton, 2011, Perinatal exposure to environmentally relevant levels of bisphenol A decreases fertility and fecundity in CD-1 mice, Environ. Health Perspect., 119, 547, 10.1289/ehp.1002559 Caserta, 2013, The influence of endocrine disruptors in a selected population of infertile women, Gynecol. Endocrinol., 29, 444, 10.3109/09513590.2012.758702 Celik, 2013, Assessment of impaired glucose tolerance prevalence with hemoglobin A1c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study, Hum. Reprod., 28, 1062, 10.1093/humrep/det002 Diamanti-Kandarakis, 2009, Endocrine-disrupting chemicals: an Endocrine Society scientific statement, Endocr. Rev., 30, 293, 10.1210/er.2009-0002 Dogan, 2014, Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome, Int. J. Endocrinol. Metab., 12 Ehrlich, 2012, Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization, Environ. Health Perspect., 120, 978, 10.1289/ehp.1104307 Fauser, 2012, Consensus on women's health aspects of polycystic ovary syndrome (PCOS), Hum. Reprod., 27, 14, 10.1093/humrep/der396 Fernandez, 2009, Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats, Environ. Health Perspect., 117, 757, 10.1289/ehp.0800267 Fernandez, 2010, Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats, Environ. Health Perspect., 118, 1217, 10.1289/ehp.0901257 Futterweit, 1999, Polycystic ovary syndrome: clinical perspectives and management, Obstet. Gynecol. Surv., 54, 403, 10.1097/00006254-199906000-00024 Ganie, 2016, Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent, Fertil. Steril., 105, 194, 10.1016/j.fertnstert.2015.09.005 Hanioka, 1998, Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver, Arch. Toxicol., 72, 387, 10.1007/s002040050518 Harrison, 2005, Platelets and thrombosis in myeloproliferative diseases, Hematol. Am. Soc. Hematol. Educ. Prog., 409, 10.1182/asheducation-2005.1.409 Jeelani, 2017, Polycystic ovary syndrome (PCOS) and related diseases, Pmj, 2, 23 Kandaraki, 2011, Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS, J. Clin. Endocrinol. Metab., 96, E480, 10.1210/jc.2010-1658 Kebapcilar, 2009, High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome, Arch. Gynecol. Obstet., 280, 187, 10.1007/s00404-008-0884-0 Kelly, 2002, Altered vascular function in young women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 742, 10.1210/jcem.87.2.8199 Lath, 2015, Insulin resistance and lipid profile in polycystic ovary syndrome, Asian J. Biomed. Pharm. Sci., 5, 30, 10.15272/ajbps.v5i47.726 Lo, 2006, Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 91, 1357, 10.1210/jc.2005-2430 March, 2010, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria, Hum. Reprod., 25, 544, 10.1093/humrep/dep399 Markey, 2003, Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs, Evol. Dev., 5, 67, 10.1046/j.1525-142X.2003.03011.x Masuno, 2005, Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway, Toxicol. Sci., 84, 319, 10.1093/toxsci/kfi088 Newbold, 2007, Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract, Reprod. Toxicol., 24, 253, 10.1016/j.reprotox.2007.07.006 Newbold, 2009, Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life, Environ. Health Perspect., 117, 879, 10.1289/ehp.0800045 Papalou, 2015, White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia, Hormones, 14, 91 Phrakonkham, 2008, Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis, J. Steroid Biochem. Mol. Biol., 110, 95, 10.1016/j.jsbmb.2008.02.006 Pilo, 1981, Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism, Thromb. Haemostasis, 46, 538, 10.1055/s-0038-1653405 Ropero, 2008, Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis, Int. J. Androl., 31, 194, 10.1111/j.1365-2605.2007.00832.x Ross, 1999, Atherosclerosis–an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Rubin, 2001, Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels, Environ. Health Perspect., 109, 675, 10.1289/ehp.01109675 Silvia, 2015, Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population, J. Transl. Med., 13, 169, 10.1186/s12967-015-0532-y Somm, 2009, Perinatal exposure to bisphenol a alters early adipogenesis in the rat, Environ. Health Perspect., 117, 1549, 10.1289/ehp.11342 Souter, 2013, The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments, Reprod. Toxicol., 42, 224, 10.1016/j.reprotox.2013.09.008 Takeuchi, 2006, Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity, Endocr. J., 53, 485, 10.1507/endocrj.K06-032 Tsilchorozidou, 2004, The pathophysiology of polycystic ovary syndrome, Clin. Endocrinol., 60, 1, 10.1046/j.1365-2265.2003.01842.x Vandenberg, 2010, Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A, Environ. Health Perspect., 118, 1055, 10.1289/ehp.0901716 Vrbikova, 2003, Cardiovascular risk factors in young Czech females with polycystic ovary syndrome, Hum. Reprod., 18, 980, 10.1093/humrep/deg218 Wada, 2007, Life style-related diseases of the digestive system: endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome, J. Pharmacol. Sci., 105, 133, 10.1254/jphs.FM0070034 Wang, 2012, Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance, J. Clin. Endocrinol. Metab., 97, E223, 10.1210/jc.2011-1989 Wild, 1985, Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 61, 946, 10.1210/jcem-61-5-946 Yildiz, 2002, Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state, J. Clin. Endocrinol. Metab., 87, 3871, 10.1210/jcem.87.8.8716 Zargar, 1997, Epidemiologic and etiologic aspects of primary infertility in the Kashmir region of India, Fertil. Steril., 68, 637, 10.1016/S0015-0282(97)00269-0 Zargar, 2002, Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent, Fertil. Steril., 77, 674, 10.1016/S0015-0282(01)03241-1 Zhao, 2012, The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women, Clin. Biochem., 45, 1602, 10.1016/j.clinbiochem.2012.08.024 Zhou, 2008, Effect of Bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells, Mol. Cell. Endocrinol., 283, 12, 10.1016/j.mce.2007.10.010